These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 6243663)
1. New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia. Levine LS; Rauh W; Gottesdiener K; Chow D; Gunczler P; Rapaport R; Pang S; Schneider B; New MI J Clin Endocrinol Metab; 1980 Feb; 50(2):258-63. PubMed ID: 6243663 [TBL] [Abstract][Full Text] [Related]
2. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia. Rodríguez Portales JA; Arteaga E; López Moreno JM; Biglieri EG J Clin Endocrinol Metab; 1988 Feb; 66(2):349-54. PubMed ID: 3276723 [TBL] [Abstract][Full Text] [Related]
3. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function. Pang S; Levine LS; Stoner E; Opitz JM; Pollack MS; Dupont B; New MI J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166 [TBL] [Abstract][Full Text] [Related]
4. The 21-hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia. Kuhnle U; Chow D; Rapaport R; Pang S; Levine LS; New MI J Clin Endocrinol Metab; 1981 Mar; 52(3):534-44. PubMed ID: 6257750 [TBL] [Abstract][Full Text] [Related]
5. The zonal origins of the mineralocorticoid hormones in the 21-hydroxylation deficiency of congenital adrenal hyperplasia. Biglieri EG; Wajchenberg BL; Malerbi DA; Okada H; Leme CE; Kater CE J Clin Endocrinol Metab; 1981 Nov; 53(5):964-9. PubMed ID: 6270186 [TBL] [Abstract][Full Text] [Related]
7. Characterization of zona glomerulosa function in patients with classic and non-classic forms of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Castro-Magana M; Angulo M; Canas JA; Mazur B; Sarrantonio M; Vitollo P; Palekar A; Fuentes B; Lee A J Pediatr Endocrinol Metab; 1995; 8(1):19-25. PubMed ID: 7584692 [TBL] [Abstract][Full Text] [Related]
8. Salt loss in hypertensive form of congenital adrenal hyperplasia (11-beta-hydroxylase deficiency). Zadik Z; Kahana L; Kaufman H; Benderli A; Hochberg Z J Clin Endocrinol Metab; 1984 Feb; 58(2):384-7. PubMed ID: 6607265 [TBL] [Abstract][Full Text] [Related]
9. The natural history of salt-wasting disorders of adrenal and renal origin. Rösler A J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251 [TBL] [Abstract][Full Text] [Related]
10. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency. Kater CE; Biglieri EG; Wajchenberg B J Clin Endocrinol Metab; 1985 Jun; 60(6):1057-62. PubMed ID: 2987285 [TBL] [Abstract][Full Text] [Related]
11. Parallelism of 11 beta- and 18-hydroxylation demonstrated by urinary free hormones in man. Sonino N; Levine LS; Vecsei P; New MI J Clin Endocrinol Metab; 1980 Sep; 51(3):557-60. PubMed ID: 6251104 [TBL] [Abstract][Full Text] [Related]
12. An autopsy case of 17 alpha-hydroxylase deficiency with malignant hypertension. Morimoto I; Maeda R; Izumi M; Ishimaru T; Nishimori I; Nagataki S J Clin Endocrinol Metab; 1983 May; 56(5):915-9. PubMed ID: 6300176 [TBL] [Abstract][Full Text] [Related]
13. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Hochberg Z; Benderly A; Kahana L; Zadik Z J Clin Endocrinol Metab; 1986 Jul; 63(1):36-40. PubMed ID: 3011843 [TBL] [Abstract][Full Text] [Related]
14. Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension. de Simone G; Tommaselli AP; Rossi R; Valentino R; Lauria R; Scopacasa F; Lombardi G Hypertension; 1985; 7(2):204-10. PubMed ID: 2984117 [TBL] [Abstract][Full Text] [Related]
15. Suppression and stimulation of mineralocorticoid hormones (MCH) in the simple virilizing form of congenital adrenal hyperplasia (CAH) evaluated by the quantitation in adrenal venous blood. Wajchenberg BL; Biglieri EG; Okada H; Malerbi DA; Achando SS; Kater CE J Steroid Biochem; 1983 Jul; 19(1B):655-61. PubMed ID: 6350722 [TBL] [Abstract][Full Text] [Related]
16. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism. Oberfield SE; Levine LS; Stoner E; Chow D; Rauh W; Greig F; Lee SM; Lightner E; Witte M; New MI J Clin Endocrinol Metab; 1981 Jul; 53(1):158-64. PubMed ID: 7016891 [TBL] [Abstract][Full Text] [Related]
17. [Malignant arterial hypertension disclosing late congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency]. Ribstein J; Sciolla JP; Barjon P; Sultan C; Forest M; de Peretti E Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():93-5. PubMed ID: 3142437 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia. Schaison G; Couzinet B; Gourmelen M; Elkik F; Bougneres P J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950 [TBL] [Abstract][Full Text] [Related]
19. Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia. Holcombe JH; Keenan BS; Nichols BL; Kirkland RT; Clayton GW Pediatrics; 1980 Apr; 65(4):777-81. PubMed ID: 6966049 [TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin-aldosterone system: a long-term follow-up study in 17 alpha-hydroxylase deficiency syndrome (17OHDS). Scaroni C; Opocher G; Mantero F Clin Exp Hypertens A; 1986; 8(4-5):773-80. PubMed ID: 3530552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]